These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8048849)

  • 1. Phenotypic variation in hereditary breast cancer. Cancer control implications.
    Lynch HT; Conway TA; Lynch JF
    Arch Surg; 1994 Aug; 129(8):806-13. PubMed ID: 8048849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary breast cancer and family cancer syndromes.
    Lynch HT; Lynch J; Conway T; Watson P; Feunteun J; Lenoir G; Narod S; Fitzgibbons R
    World J Surg; 1994; 18(1):21-31. PubMed ID: 8197773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
    Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P
    Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel p.Gly187Arg TP53 variant appears to result in Li-Fraumeni syndrome.
    Doyle MR; Johnston JM
    Pediatr Hematol Oncol; 2018 Apr; 35(3):203-207. PubMed ID: 30239254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes.
    Lynch HT; Silva E; Snyder C; Lynch JF
    Breast J; 2008; 14(1):3-13. PubMed ID: 18086272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
    JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.
    Gabaldó Barrios X; Sarabia Meseguer MD; Marín Vera M; Sánchez Bermúdez AI; Macías Cerrolaza JA; Sánchez Henarejos P; Zafra Poves M; García Hernández MR; Cuevas Tortosa E; Aliaga Baño Á; Castillo Guardiola V; Martínez Hernández P; Tovar Zapata I; Martínez Barba E; Ayala de la Peña F; Alonso Romero JL; Noguera Velasco JA; Ruiz Espejo F
    Fam Cancer; 2017 Oct; 16(4):477-489. PubMed ID: 28477318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic evaluation based on family history and Her2 status correctly identifies TP53 mutations in very early onset breast cancer cases.
    Fostira F; Konstantopoulou I; Mavroudis D; Tryfonopoulos D; Yannoukakos D; Voutsinas GE
    Clin Genet; 2015 Apr; 87(4):383-7. PubMed ID: 24702488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
    Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
    Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetics and cancer of the breast].
    Sobol H; Bignon YJ; Eisinger F; Birnbaum D; Fervers B
    Ann Chir; 1994; 48(4):303-8. PubMed ID: 8085754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical/genetic features in hereditary breast cancer.
    Lynch HT; Watson P; Conway TA; Lynch JF
    Breast Cancer Res Treat; 1990 Feb; 15(2):63-71. PubMed ID: 2322650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity and natural history of hereditary breast cancer. Surgical implications.
    Lynch HT; Fitzgibbons RJ; Lynch JF
    Surg Clin North Am; 1990 Aug; 70(4):753-74. PubMed ID: 2196704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
    J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population.
    Darooei M; Poornima S; Salma BU; Iyer GR; Pujar AN; Annapurna S; Shah A; Maddali S; Hasan Q
    Tumour Biol; 2017 Feb; 39(2):1010428317694303. PubMed ID: 28231738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing for cancer predisposition.
    Eng C; Hampel H; de la Chapelle A
    Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary ovarian cancer. Heterogeneity in age at onset.
    Lynch HT; Watson P; Lynch JF; Conway TA; Fili M
    Cancer; 1993 Jan; 71(2 Suppl):573-81. PubMed ID: 8420679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.
    Lynch HT; Snyder CL; Lynch JF; Riley BD; Rubinstein WS
    J Clin Oncol; 2003 Feb; 21(4):740-53. PubMed ID: 12586815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.